Dextera Surgical Inc. (NASDAQ:DXTR)’s share price was down NaN during mid-day trading on Friday . The company traded as low as $0.22 and last traded at $0.00. Approximately 2,187,300 shares were traded during trading, an increase of Infinity from the average daily volume of 0 shares.

A number of equities analysts have issued reports on DXTR shares. Wedbush cut their target price on shares of Dextera Surgical from $3.50 to $0.70 and set an “outperform” rating for the company in a research report on Wednesday, July 12th. Zacks Investment Research upgraded shares of Dextera Surgical from a “strong sell” rating to a “hold” rating in a research report on Tuesday. Finally, Ladenburg Thalmann Financial Services started coverage on shares of Dextera Surgical in a research report on Wednesday, August 16th. They set a “buy” rating and a $0.80 target price for the company.

Dextera Surgical (NASDAQ:DXTR) last posted its quarterly earnings data on Tuesday, August 8th. The medical instruments supplier reported ($0.40) EPS for the quarter, missing analysts’ consensus estimates of ($0.11) by ($0.29). The business had revenue of $1.05 million for the quarter, compared to the consensus estimate of $1.03 million.

A number of large investors have recently added to or reduced their stakes in DXTR. Perkins Capital Management Inc. acquired a new position in Dextera Surgical in the second quarter worth approximately $100,000. Virtu KCG Holdings LLC boosted its position in shares of Dextera Surgical by 1,380.6% in the second quarter. Virtu KCG Holdings LLC now owns 369,918 shares of the medical instruments supplier’s stock valued at $111,000 after acquiring an additional 344,933 shares during the period. Finally, Broadfin Capital LLC boosted its position in shares of Dextera Surgical by 64.7% in the second quarter. Broadfin Capital LLC now owns 987,520 shares of the medical instruments supplier’s stock valued at $296,000 after acquiring an additional 388,080 shares during the period. Hedge funds and other institutional investors own 6.58% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This article was originally reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this article on another publication, it was illegally copied and reposted in violation of U.S. & international trademark & copyright law. The correct version of this article can be accessed at https://www.thecerbatgem.com/2017/10/13/dextera-surgical-inc-dxtr-trading-down-nan.html.

Dextera Surgical Company Profile

Dextera Surgical Inc, formerly Cardica, Inc, designs and manufactures stapling devices that enable the advancement of minimally invasive surgical procedures. The Company is engaged in commercializing and developing its MicroCutter 5/80 stapler based on its staple-on-a-strip technology for use by thoracic, pediatric, bariatric, colorectal and general surgeons.

Receive News & Stock Ratings for Dextera Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dextera Surgical Inc. and related stocks with our FREE daily email newsletter.